MANNKIND CORP Class of Warrant or Right, Outstanding
MANNKIND CORP (MNKD) had Class of Warrant or Right, Outstanding of 32.00 thousand shares as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2018-02-27
- 2017-12-31: Class of Warrant or Right, Outstanding 32.00K shares.
- 2015-11-16: Class of Warrant or Right, Outstanding 32.00K shares; Class of Warrant or Right, Outstanding as first filed 159.30K shares.
- 2013-12-31: Class of Warrant or Right, Outstanding 32.84M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2017-12-31 | 32.00K shares 10-K · filed 2018-02-27 | |
| 2015-11-16 | 32.00K shares 10-K · filed 2018-02-27 | 159.30K shares 10-K · filed 2016-03-15 |
| 2013-12-31 | 32.84M shares 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |